Non-PML neuroinvasive infections reported with multiple sclerosis disease-modifying therapies: a mechanism-based pharmacovigilance study, 2004–2025

Li Ke, Sili Jiang, Jian Duan, Wenli Xing

Open source

DOI
10.3389/fimmu.2026.1959164
Published
2026-10-13
Container
Frontiers in Immunology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1959164,
  title = {Non-PML neuroinvasive infections reported with multiple sclerosis disease-modifying therapies: a mechanism-based pharmacovigilance study, 2004–2025},
  author = {Li Ke and Sili Jiang and Jian Duan and Wenli Xing},
  year = {2026},
  journal = {Frontiers in Immunology},
  doi = {10.3389/fimmu.2026.1959164},
  url = {https://doi.org/10.3389/fimmu.2026.1959164}
}

RIS

TY  - JOUR
TI  - Non-PML neuroinvasive infections reported with multiple sclerosis disease-modifying therapies: a mechanism-based pharmacovigilance study, 2004–2025
AU  - Li Ke
AU  - Sili Jiang
AU  - Jian Duan
AU  - Wenli Xing
PY  - 2026
JO  - Frontiers in Immunology
DO  - 10.3389/fimmu.2026.1959164
UR  - https://doi.org/10.3389/fimmu.2026.1959164
ER  - 

APA

Ke, L., Jiang, S., Duan, J., & Xing, W. (2026). Non-PML neuroinvasive infections reported with multiple sclerosis disease-modifying therapies: a mechanism-based pharmacovigilance study, 2004–2025. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2026.1959164

Source records